NASDAQ:AXGN - AxoGen Stock Price, Price Target & More

$40.65 +0.95 (+2.39 %)
(As of 04/19/2018 09:30 AM ET)
Previous Close$39.70
Today's Range$39.45 - $40.70
52-Week Range$11.30 - $40.95
Volume258,700 shs
Average Volume336,327 shs
Market Capitalization$1.37 billion
P/E Ratio-131.13
Dividend YieldN/A
Beta0.01

About AxoGen (NASDAQ:AXGN)

AxoGen logoAxoGen, Inc. develops and markets surgical solutions for peripheral nerve injuries. The company's surgical solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

Receive AXGN News and Ratings via Email

Sign-up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AXGN
CUSIPN/A
Phone386-462-6800

Debt

Debt-to-Equity Ratio0.79%
Current Ratio4.07%
Quick Ratio3.53%

Price-To-Earnings

Trailing P/E Ratio-131.13
Forward P/E Ratio-135.50
P/E GrowthN/A

Sales & Book Value

Annual Sales$60.43 million
Price / Sales23.25
Cash FlowN/A
Price / CashN/A
Book Value$0.74 per share
Price / Book54.93

Profitability

EPS (Most Recent Fiscal Year)($0.31)
Net Income$-10,440,000.00
Net Margins-17.29%
Return on Equity-70.63%
Return on Assets-22.33%

Miscellaneous

Employees199
Outstanding Shares34,560,000

How to Become a New Pot Stock Millionaire

AxoGen (NASDAQ:AXGN) Frequently Asked Questions

What is AxoGen's stock symbol?

AxoGen trades on the NASDAQ under the ticker symbol "AXGN."

How were AxoGen's earnings last quarter?

AxoGen, Inc (NASDAQ:AXGN) issued its earnings results on Wednesday, February, 28th. The medical equipment provider reported ($0.07) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.09) by $0.02. The medical equipment provider had revenue of $16.97 million for the quarter, compared to analysts' expectations of $16.38 million. AxoGen had a negative return on equity of 70.63% and a negative net margin of 17.29%. The business's revenue was up 48.7% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.10) earnings per share. View AxoGen's Earnings History.

What price target have analysts set for AXGN?

8 brokerages have issued 1-year price targets for AxoGen's stock. Their predictions range from $21.00 to $45.00. On average, they expect AxoGen's share price to reach $33.1429 in the next twelve months. View Analyst Ratings for AxoGen.

Who are some of AxoGen's key competitors?

Who are AxoGen's key executives?

AxoGen's management team includes the folowing people:
  • Ms. Karen Zaderej, Pres, CEO & Director (Age 56)
  • Mr. Peter J. Mariani, CFO & Principal Accounting Officer (Age 54)
  • Mr. Gregory G. Freitag, Gen. Counsel, Sr. VP of Bus. Devel. & Director (Age 56)
  • Mr. Shawn F. McCarrey, Sr. VP of Sales (Age 60)
  • Mr. Jon S. Gingrich, Chief Commercial Officer (Age 49)

Has AxoGen been receiving favorable news coverage?

News coverage about AXGN stock has trended positive on Thursday, according to Accern Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. AxoGen earned a news sentiment score of 0.30 on Accern's scale. They also gave media coverage about the medical equipment provider an impact score of 44.14 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of AxoGen?

Shares of AXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AxoGen's stock price today?

One share of AXGN stock can currently be purchased for approximately $40.65.

How big of a company is AxoGen?

AxoGen has a market capitalization of $1.37 billion and generates $60.43 million in revenue each year. The medical equipment provider earns $-10,440,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. AxoGen employs 199 workers across the globe.

How can I contact AxoGen?

AxoGen's mailing address is 13631 PROGRESS BLVD. SUITE 400, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-462-6800 or via email at [email protected]


MarketBeat Community Rating for AxoGen (AXGN)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  182 (Vote Outperform)
Underperform Votes:  88 (Vote Underperform)
Total Votes:  270
MarketBeat's community ratings are surveys of what our community members think about AxoGen and other stocks. Vote "Outperform" if you believe AXGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AXGN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

AxoGen (NASDAQ:AXGN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for AxoGen in the last 12 months. Their average twelve-month price target is $33.1429, suggesting that the stock has a possible downside of 18.47%. The high price target for AXGN is $45.00 and the low price target for AXGN is $21.00. There are currently 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $33.1429$33.1429$29.3333$17.40
Price Target Upside: 18.47% downside11.97% downside5.53% downside10.08% downside

AxoGen (NASDAQ:AXGN) Consensus Price Target History

Price Target History for AxoGen (NASDAQ:AXGN)

AxoGen (NASDAQ:AXGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/19/2018Jefferies GroupBoost Price TargetBuy$45.00MediumView Rating Details
3/2/2018Lake Street CapitalSet Price TargetBuy -> Buy$26.00 -> $38.00MediumView Rating Details
3/1/2018JMP SecuritiesBoost Price TargetMarket Outperform$27.00 -> $34.00HighView Rating Details
2/5/2018William BlairInitiated CoverageOutperformHighView Rating Details
1/8/2018Cantor FitzgeraldSet Price TargetBuy$37.00HighView Rating Details
11/21/2017Leerink SwannBoost Price TargetOutperform -> Outperform$26.00 -> $30.00N/AView Rating Details
11/21/2017WedbushReiterated RatingBuy$22.00 -> $27.00N/AView Rating Details
9/12/2017Roth CapitalReiterated RatingBuy$18.00 -> $21.00LowView Rating Details
(Data available from 4/19/2016 forward)

Earnings

AxoGen (NASDAQ:AXGN) Earnings History and Estimates Chart

Earnings by Quarter for AxoGen (NASDAQ:AXGN)

AxoGen (NASDAQ:AXGN) Earnings Estimates

2018 EPS Consensus Estimate: ($0.21)
2019 EPS Consensus Estimate: ($0.09)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184($0.15)$0.01($0.08)
Q2 20184($0.08)$0.03($0.03)
Q3 20184($0.08)$0.04($0.03)
Q4 20183($0.09)($0.05)($0.07)
Q1 20192($0.04)($0.04)($0.04)
Q2 20192($0.04)($0.04)($0.04)
Q3 20192($0.04)($0.02)($0.03)
Q4 20191$0.02$0.02$0.02

AxoGen (NASDAQ AXGN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2018Q4 2017($0.09)($0.07)$16.38 million$16.97 millionViewListenView Earnings Details
11/1/2017Q3 2017($0.06)($0.06)$15.55 million$16.05 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.08)($0.06)$14.40 million$15.20 millionViewListenView Earnings Details
5/4/2017Q1 2017($0.10)($0.11)$11.83 million$12.24 millionViewListenView Earnings Details
2/22/2017Q4 2016($0.09)($0.10)$11.41 millionViewListenView Earnings Details
11/2/2016Q3 2016($0.08)($0.08)$11.21 million$11.21 millionViewN/AView Earnings Details
8/3/2016Q2($0.12)($0.09)$9.28 million$10.38 millionViewN/AView Earnings Details
5/4/2016Q1 2016($0.13)($0.12)$7.74 million$8.11 millionViewN/AView Earnings Details
2/29/2016Q4 2015($0.11)($0.12)$7.13 million$7.81 millionViewN/AView Earnings Details
11/5/2015Q3 2015($0.12)($0.11)$6.70 million$8.15 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.15)($0.13)$5.89 million$6.42 millionViewN/AView Earnings Details
5/5/2015Q1 2015($0.17)($0.16)$4.90 million$4.95 millionViewN/AView Earnings Details
3/5/2015Q4 2014($0.18)($0.36)$4.74 million$4.79 millionViewN/AView Earnings Details
11/13/2014Q3 2014($0.24)($0.19)$4.67 millionViewN/AView Earnings Details
8/4/2014Q2 2014($0.22)($0.21)$3.30 million$4.21 millionViewN/AView Earnings Details
4/30/2014Q1 2014($0.26)($0.24)$2.75 million$3.14 millionViewN/AView Earnings Details
3/6/2014($0.22)($0.24)$3.17 million$2.99 millionViewN/AView Earnings Details
10/30/2013Q3 2013($0.20)($0.25)$3.07 million$2.96 millionViewN/AView Earnings Details
8/14/2013Q2 2013($0.31)$2.86 million$2.86 millionViewN/AView Earnings Details
4/30/2013Q1 2013($0.26)($0.31)$2.53 million$2.14 millionViewN/AView Earnings Details
3/12/2013Q4 2012($0.23)($0.36)ViewN/AView Earnings Details
11/7/2012Q3 2012($0.17)($0.20)ViewN/AView Earnings Details
8/14/2012Q2 2012($0.19)($0.15)ViewN/AView Earnings Details
5/14/2012Q1 2012($0.19)($0.19)ViewN/AView Earnings Details
11/9/2011Q3 2011($2.60)ViewN/AView Earnings Details
8/11/2011Q2 2011$0.06ViewN/AView Earnings Details
5/17/2011Q1 2011$0.21ViewN/AView Earnings Details
3/30/2011Q4 2010($0.09)ViewN/AView Earnings Details
11/15/2010Q3 2010($0.11)ViewN/AView Earnings Details
8/16/2010Q2 2010($0.05)ViewN/AView Earnings Details
5/17/2010Q1 2010($0.06)ViewN/AView Earnings Details
3/31/2009Q4 2008($0.02)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

AxoGen (NASDAQ:AXGN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

AxoGen (NASDAQ AXGN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.86%
Institutional Ownership Percentage: 67.78%
Insider Trading History for AxoGen (NASDAQ:AXGN)
Institutional Ownership by Quarter for AxoGen (NASDAQ:AXGN)

AxoGen (NASDAQ AXGN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2018Jamie Mark GroomsDirectorSell63,395$27.67$1,754,139.655,827View SEC Filing  
2/15/2018Jamie Mark GroomsCFOSell95,712$26.84$2,568,910.08View SEC Filing  
2/13/2018Jamie Mark GroomsCFOSell10,300$26.21$269,963.00View SEC Filing  
12/12/2017Jamie Mark GroomsDirectorSell38,405$26.35$1,011,971.75View SEC Filing  
12/8/2017Jamie Mark GroomsDirectorSell84,295$26.38$2,223,702.10View SEC Filing  
12/6/2017Jamie Mark GroomsDirectorSell21,290$26.22$558,223.80View SEC Filing  
11/20/2017Guido J NeelsDirectorSell1,150,000$19.74$22,701,000.00View SEC Filing  
9/11/2017Robert James RudeliusDirectorSell16,143$18.00$290,574.0043,273View SEC Filing  
10/7/2016Amy Mcbride WendellDirectorBuy13,333$7.50$99,997.5013,333View SEC Filing  
10/7/2016John P EngelsVPBuy4,000$7.50$30,000.0098,425View SEC Filing  
10/7/2016Karen L ZaderejCEOBuy10,000$7.50$75,000.00242,147View SEC Filing  
10/7/2016Peter J MarianiCFOBuy3,333$7.50$24,997.503,333View SEC Filing  
8/9/2016Joseph M MandatoDirectorSell149,618$8.54$1,277,737.72View SEC Filing  
8/8/2016Joseph M MandatoDirectorSell107,450$8.63$927,293.50View SEC Filing  
7/21/2016James E FlynnInsiderSell102,136$6.70$684,311.20View SEC Filing  
7/18/2016James E FlynnInsiderSell279,303$7.53$2,103,151.59View SEC Filing  
9/18/2015James E FlynnInsiderSell345,000$5.50$1,897,500.00View SEC Filing  
6/3/2015Joseph M MandatoDirectorBuy6,500$3.10$20,150.00View SEC Filing  
6/2/2015Lee Robert Johnston JrInsiderBuy5,000$3.06$15,300.00View SEC Filing  
4/8/2015James E FlynnInsiderSell144,385$3.25$469,251.25View SEC Filing  
12/10/2014Lee Robert Johnston JrCFOBuy10,000$3.06$30,600.00View SEC Filing  
8/12/2014Mark Stephen GoldDirectorBuy20,000$2.29$45,800.00View SEC Filing  
8/8/2014Mark Stephen GoldDirectorBuy11,000$2.31$25,410.00View SEC Filing  
6/6/2014Lee Robert Johnston JrCFOBuy10,000$2.58$25,800.00View SEC Filing  
6/3/2014Gregory Gene FreitagCFOBuy5,200$2.45$12,740.00View SEC Filing  
6/3/2014Karen L ZaderejCEOBuy5,000$2.43$12,150.00View SEC Filing  
5/20/2014Jill F SchiaparelliSVPBuy2,000$2.63$5,260.00View SEC Filing  
5/12/2014Karen L ZaderejCEOBuy5,000$2.70$13,500.00View SEC Filing  
5/7/2014Mark Stephen GoldDirectorBuy1,977$2.60$5,140.20View SEC Filing  
3/13/2014Karen L ZaderejCEOBuy1,500$3.49$5,235.00View SEC Filing  
8/29/2013Shawn F MccarreySVPBuy25,000$3.21$80,250.00View SEC Filing  
8/24/2013Shawn F MccarreySVPBuy5,000$3.00$15,000.00View SEC Filing  
8/14/2013Jill F SchiaparelliSVPBuy5,000$3.00$15,000.00View SEC Filing  
8/14/2013John Frederick HarperDirectorBuy66,666$3.00$199,998.00View SEC Filing  
8/14/2013Karen L ZaderejCEOBuy8,334$3.00$25,002.00View SEC Filing  
12/4/2012Jill F SchiaparelliSVPBuy2,000$2.55$5,100.00View SEC Filing  
11/29/2012Jill F SchiaparelliSVPBuy1,000$2.70$2,700.00View SEC Filing  
11/15/2012Jill F SchiaparelliSVPBuy2,750$2.56$7,040.00View SEC Filing  
10/1/2012John Frederick HarperDirectorBuy86,557$3.61$312,470.77View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

AxoGen (NASDAQ AXGN) News Headlines

Source:
DateHeadline
AxoGen, Inc. to Report First Quarter 2018 Financial Results and Host Conference Call on April 30, 2018AxoGen, Inc. to Report First Quarter 2018 Financial Results and Host Conference Call on April 30, 2018
finance.yahoo.com - April 18 at 9:29 AM
AxoGen, Inc. to Report First Quarter 2018 Financial Results  and Host Conference Call on April 30, 2018AxoGen, Inc. to Report First Quarter 2018 Financial Results and Host Conference Call on April 30, 2018
feeds.benzinga.com - April 18 at 7:52 AM
Zacks: Brokerages Expect AxoGen, Inc (AXGN) Will Post Quarterly Sales of $17.21 MillionZacks: Brokerages Expect AxoGen, Inc (AXGN) Will Post Quarterly Sales of $17.21 Million
www.americanbankingnews.com - April 18 at 3:58 AM
AxoGen, Inc (AXGN) Expected to Announce Earnings of -$0.11 Per ShareAxoGen, Inc (AXGN) Expected to Announce Earnings of -$0.11 Per Share
www.americanbankingnews.com - April 16 at 9:21 AM
AxoGen (AXGN) Receives New Coverage from Analysts at Leerink SwannAxoGen (AXGN) Receives New Coverage from Analysts at Leerink Swann
www.americanbankingnews.com - April 15 at 9:45 AM
AxoGen (AXGN) Lowered to Hold at BidaskClubAxoGen (AXGN) Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 13 at 4:55 PM
AxoGen Offers An Exciting Story At Nosebleed PricesAxoGen Offers An Exciting Story At Nosebleed Prices
seekingalpha.com - April 12 at 4:26 PM
AxoGen, Inc. Announces 2018 Annual Shareholders MeetingAxoGen, Inc. Announces 2018 Annual Shareholders' Meeting
globenewswire.com - April 12 at 10:21 AM
AxoGen (AXGN) and Sonova (SONVY) Financial ComparisonAxoGen (AXGN) and Sonova (SONVY) Financial Comparison
www.americanbankingnews.com - April 10 at 11:31 PM
Comparing AxoGen (AXGN) and Its CompetitorsComparing AxoGen (AXGN) and Its Competitors
www.americanbankingnews.com - April 10 at 9:15 AM
Head-To-Head Comparison: AxoGen (AXGN) vs. Its RivalsHead-To-Head Comparison: AxoGen (AXGN) vs. Its Rivals
www.americanbankingnews.com - April 9 at 11:18 PM
Analyzing AxoGen (AXGN) and The CompetitionAnalyzing AxoGen (AXGN) and The Competition
www.americanbankingnews.com - April 6 at 5:13 PM
AxoGen (AXGN) and Its Rivals Financial SurveyAxoGen (AXGN) and Its Rivals Financial Survey
www.americanbankingnews.com - April 4 at 11:47 AM
AxoGen (AXGN) Price Target Raised to $26.00 at Leerink SwannAxoGen (AXGN) Price Target Raised to $26.00 at Leerink Swann
www.americanbankingnews.com - April 1 at 10:52 PM
AxoGen, Inc. (AXGN) Given Consensus Rating of "Buy" by BrokeragesAxoGen, Inc. (AXGN) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - April 1 at 8:03 AM
Zacks: Analysts Anticipate AxoGen, Inc. (AXGN) Will Announce Quarterly Sales of $17.21 MillionZacks: Analysts Anticipate AxoGen, Inc. (AXGN) Will Announce Quarterly Sales of $17.21 Million
www.americanbankingnews.com - April 1 at 4:02 AM
 Brokerages Expect AxoGen, Inc. (AXGN) to Post -$0.11 Earnings Per Share Brokerages Expect AxoGen, Inc. (AXGN) to Post -$0.11 Earnings Per Share
www.americanbankingnews.com - March 30 at 11:28 AM
AxoGen (AXGN) Downgraded by BidaskClubAxoGen (AXGN) Downgraded by BidaskClub
www.americanbankingnews.com - March 28 at 9:49 PM
AxoGen (AXGN) Enters Overbought Territory March 27, 2018AxoGen (AXGN) Enters Overbought Territory March 27, 2018
www.zacks.com - March 27 at 4:23 PM
AxoGen (AXGN) Enters Overbought TerritoryAxoGen (AXGN) Enters Overbought Territory
finance.yahoo.com - March 27 at 4:23 PM
Jefferies Group Increases AxoGen (AXGN) Price Target to $45.00Jefferies Group Increases AxoGen (AXGN) Price Target to $45.00
www.americanbankingnews.com - March 19 at 11:11 AM
Zacks: Brokerages Expect AxoGen, Inc. (AXGN) Will Announce Earnings of -$0.11 Per ShareZacks: Brokerages Expect AxoGen, Inc. (AXGN) Will Announce Earnings of -$0.11 Per Share
www.americanbankingnews.com - March 13 at 12:03 PM
Brokers Issue Forecasts for AxoGen, Inc.s FY2018 Earnings (AXGN)Brokers Issue Forecasts for AxoGen, Inc.'s FY2018 Earnings (AXGN)
www.americanbankingnews.com - March 7 at 11:48 AM
AxoGen, Inc. (AXGN) Receives Consensus Recommendation of "Buy" from BrokeragesAxoGen, Inc. (AXGN) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - March 7 at 11:45 AM
Blog Exposure - Boston Scientific Acquired EMcision for Undisclosed AmountBlog Exposure - Boston Scientific Acquired EMcision for Undisclosed Amount
finance.yahoo.com - March 7 at 9:36 AM
AWM Investment Company Inc. Has $7.97 Million Holdings in AxoGen, Inc. (AXGN)AWM Investment Company Inc. Has $7.97 Million Holdings in AxoGen, Inc. (AXGN)
www.americanbankingnews.com - March 6 at 4:44 AM
Are Earnings Prospects Improving For Loss-Making AxoGen Inc’s (NASDAQ:AXGN)?Are Earnings Prospects Improving For Loss-Making AxoGen Inc’s (NASDAQ:AXGN)?
finance.yahoo.com - March 5 at 5:00 PM
AxoGen, Inc. (AXGN) Position Lowered by Millrace Asset Group Inc.AxoGen, Inc. (AXGN) Position Lowered by Millrace Asset Group Inc.
www.americanbankingnews.com - March 5 at 12:54 PM
Q3 2018 Earnings Estimate for AxoGen, Inc. Issued By William Blair (AXGN)Q3 2018 Earnings Estimate for AxoGen, Inc. Issued By William Blair (AXGN)
www.americanbankingnews.com - March 5 at 4:30 AM
Q1 2018 EPS Estimates for AxoGen, Inc. Reduced by Leerink Swann (AXGN)Q1 2018 EPS Estimates for AxoGen, Inc. Reduced by Leerink Swann (AXGN)
www.americanbankingnews.com - March 5 at 2:56 AM
Jefferies Group Comments on AxoGen, Inc.s Q1 2018 Earnings (AXGN)Jefferies Group Comments on AxoGen, Inc.'s Q1 2018 Earnings (AXGN)
www.americanbankingnews.com - March 5 at 2:56 AM
Contrasting Zynex (ZYXI) & AxoGen (AXGN)Contrasting Zynex (ZYXI) & AxoGen (AXGN)
www.americanbankingnews.com - March 4 at 12:02 PM
AxoGen Inc. (AXGN) Has Broken Out To A New High On Q4 Results - NasdaqAxoGen Inc. (AXGN) Has Broken Out To A New High On Q4 Results - Nasdaq
www.nasdaq.com - March 3 at 5:09 PM
AxoGen (AXGN) Q4 2017 Earnings Conference Call Transcript - Motley FoolAxoGen (AXGN) Q4 2017 Earnings Conference Call Transcript - Motley Fool
www.fool.com - March 3 at 5:09 PM
AxoGen (AXGN) PT Set at $38.00 by Lake Street CapitalAxoGen (AXGN) PT Set at $38.00 by Lake Street Capital
www.americanbankingnews.com - March 2 at 7:48 PM
AxoGen, Inc. (AXGN) is Next Century Growth Investors LLCs 5th Largest PositionAxoGen, Inc. (AXGN) is Next Century Growth Investors LLC's 5th Largest Position
www.americanbankingnews.com - March 2 at 5:58 PM
Brokers Offer Predictions for AxoGen, Inc.s FY2020 Earnings (AXGN)Brokers Offer Predictions for AxoGen, Inc.'s FY2020 Earnings (AXGN)
www.americanbankingnews.com - March 2 at 5:10 PM
AxoGen (AXGN) Q4 2017 Earnings Conference Call TranscriptAxoGen (AXGN) Q4 2017 Earnings Conference Call Transcript
finance.yahoo.com - March 2 at 5:05 PM
AxoGen (AXGN) PT Raised to $34.00 at JMP SecuritiesAxoGen (AXGN) PT Raised to $34.00 at JMP Securities
www.americanbankingnews.com - March 1 at 7:07 PM
AxoGen, Inc. (AXGN) Shares Sold by Essex Woodlands Management Inc.AxoGen, Inc. (AXGN) Shares Sold by Essex Woodlands Management Inc.
www.americanbankingnews.com - March 1 at 2:12 PM
AxoGen (AXGN) Announces Quarterly  Earnings ResultsAxoGen (AXGN) Announces Quarterly Earnings Results
www.americanbankingnews.com - February 28 at 9:20 PM
BRIEF-Axogen Inc Q4 Adjusted Loss Per Share $0.07BRIEF-Axogen Inc Q4 Adjusted Loss Per Share $0.07
www.reuters.com - February 28 at 4:59 PM
AxoGen, Inc. to Host Earnings CallAxoGen, Inc. to Host Earnings Call
finance.yahoo.com - February 28 at 4:59 PM
AxoGen, Inc. Reports 2017 Fourth Quarter and Full Year Financial ResultsAxoGen, Inc. Reports 2017 Fourth Quarter and Full Year Financial Results
finance.yahoo.com - February 28 at 4:59 PM
EAM Investors LLC Sells 73,412 Shares of AxoGen, Inc. (AXGN)EAM Investors LLC Sells 73,412 Shares of AxoGen, Inc. (AXGN)
www.americanbankingnews.com - February 27 at 3:00 PM
AxoGen, Inc. (AXGN) Position Cut by Cortina Asset Management LLCAxoGen, Inc. (AXGN) Position Cut by Cortina Asset Management LLC
www.americanbankingnews.com - February 27 at 1:40 PM
AxoGen, Inc. to Present at 30th Annual ROTH ConferenceAxoGen, Inc. to Present at 30th Annual ROTH Conference
finance.yahoo.com - February 27 at 9:30 AM
AxoGen Named Employee Engagement Best Practices Award Winner by DecisionWise InternationalAxoGen Named Employee Engagement Best Practices Award Winner by DecisionWise International
finance.yahoo.com - February 27 at 9:30 AM
Zacks: Analysts Anticipate AxoGen, Inc. (AXGN) Will Announce Quarterly Sales of $16.09 MillionZacks: Analysts Anticipate AxoGen, Inc. (AXGN) Will Announce Quarterly Sales of $16.09 Million
www.americanbankingnews.com - February 26 at 4:38 AM
BidaskClub Upgrades AxoGen (AXGN) to "Strong-Buy"BidaskClub Upgrades AxoGen (AXGN) to "Strong-Buy"
www.americanbankingnews.com - February 25 at 12:00 AM

SEC Filings

AxoGen (NASDAQ:AXGN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

AxoGen (NASDAQ:AXGN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

AxoGen (NASDAQ AXGN) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.